STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Defensive Interval Ratio
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Defensive Interval Ratio of 282 days as of June 2025. Defensive assets of €4.04 Million (cash €-, short-term investments €-, receivables €4.04 Million) cover 282 days of daily cash needs of €14.32K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
STARPHARMA HLDG.SP.ADR/10 Defensive Interval Ratio (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 282 days, meaning defensive assets of €4.04 Million can fund 282 days of operations without new revenue. For the complete balance sheet picture, see PQ6A total assets.
Annual Defensive Interval Ratio for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is STARPHARMA HLDG.SP.ADR/10's working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 282 days | €4.04 Million | €14.32K/day | €- | €- | ▼ -52 days |
| 2024 | 334 days | €6.09 Million | €18.25K/day | €- | €- | ▲ +136 days |
| 2023 | 198 days | €7.86 Million | €39.65K/day | €- | €- | ▼ -62 days |
| 2022 | 260 days | €7.29 Million | €28.03K/day | €- | €- | — |